TNNC1

Troponin C, slow skeletal and cardiac muscles · P63316 · TNNC1 on Sugi Atlas →

20,845 patent compounds predicted against TNNC1, 13,568 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Fingolimod Fingolimod (SCHEMBL7445) 1.00 6/20
Fingolimod Fingolimod (SCHEMBL81362) 0.97 6/20
SCHEMBL565320 SCHEMBL565320 0.58 6/20
SCHEMBL775505 SCHEMBL775505 0.58 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL565883) 0.52 6/20
SCHEMBL140913 SCHEMBL140913 0.50 6/20
SCHEMBL566250 SCHEMBL566250 0.50 6/20
SCHEMBL566429 SCHEMBL566429 0.49 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL567052) 0.48 6/20
SCHEMBL566651 SCHEMBL566651 0.48 6/20
SCHEMBL86409 SCHEMBL86409 0.45 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL80436) 0.44 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL80437) 0.44 6/20
SCHEMBL86393 SCHEMBL86393 0.43 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL79318) 0.43 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL79319) 0.43 6/20
SCHEMBL86450 SCHEMBL86450 0.43 6/20
SCHEMBL86426 SCHEMBL86426 0.42 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL80616) 0.42 6/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL80617) 0.42 6/20

Clinical trials — most relevant to TNNC1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy PHASE4UNKNOWN
Levosimendan in Acute Decompensated Heart Failure PHASE2/PHASE3NOT_YET_RECRUITING
Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children PHASE3COMPLETED
Chronic Sildenafil Treatment in Heart Failure PHASE3COMPLETED
Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings nanUNKNOWN
TROPOnin FRAGMentation in Myocardial Injury Study nanRECRUITING
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases nanCOMPLETED
A Cardiac Registry to Evaluate and Manage the hsTnI Categorical CVD Risk in Subjects Undergoing Preventive Health Checks (PHC). nanSUSPENDED
Cardiac Injury With Convulsive Status Epilepticus nanUNKNOWN
Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease nanACTIVE_NOT_RECRUITING
Out-of-hospital Cardiac Arrest (OHCA) Biomarkers nanCOMPLETED
Heart and Skeletal Muscle Problems in Neuroacanthocytosis nanCOMPLETED
Sleep Disordered Breathing in Acute Congestive Heart Failure nanCOMPLETED
Rheumatoid Arthritis Disease Activity and Sub Clinical Atherosclerosis nanCOMPLETED
Observational Study on Cardiac Biomarkers Testing in Patients with Muscular Dystrophy Cardiomyopathy nanCOMPLETED
Study of Myocardial Function by Speckle Tracking After Cancer Treatment With Anthracyclines in Childhood nanCOMPLETED
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction nanWITHDRAWN
Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction nanCOMPLETED
Finding Acute Coronary Syndromes (ACS) With Serial Troponin Testing for Rapid Assessment of Cardiac Ischemic Symptoms nanUNKNOWN
Transcutaneous Functional Magnetic Muscle Stimulation in Critically Ill nanUNKNOWN
Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy nanUNKNOWN
Early Detection of Cardiomyopathy by Speckle Echo, High Sensitive Troponin and Cardiac Ryanodine Receptors nanUNKNOWN
Preoperative BNP: Epidemiological Patterns, Management Strategies and Cost Analysis of Care nanCOMPLETED
COronary Microcirculation and Troponin Elevation in Septic Shock nanCOMPLETED
SpinChip Hs-cTnI Determination of the 99th Percentile URL nanCOMPLETED
Hypersensitive Troponin Performance to Identify Syncope at Risk of Serious Adverse Events in the Short Term nanUNKNOWN
Risk Markers in the Acute Coronary Syndromes nanCOMPLETED
ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study nanCOMPLETED
MACCE in Hospitalized Patients With Community-acquired Pneumonia nanUNKNOWN
5th Generation cTnT in ED ACS nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TNNC1 binder may also engage these)

ProteinNameSimilarity
P02591 1.000 P02591 →
P63315 1.000 P63315 →
P63317 1.000 P63317 →
P09860 1.000 P09860 →
P19123 1.000 P19123 →
P05936 1.000 P05936 →
P02589 1.000 P02589 →
P02588 1.000 P02588 →
P02585 1.000 P02585 →
P10246 0.998 P10246 →
P81660 0.996 P81660 →
Q3SB11 0.995 Q3SB11 →
Q3SB08 0.995 Q3SB08 →
Q3SB12 0.995 Q3SB12 →
P02587 0.994 P02587 →
P20801 0.993 P20801 →
P47948 0.993 P47948 →
P29291 0.993 P29291 →
Q8AY75 0.993 Q8AY75 →
Q3SB09 0.993 Q3SB09 →
P06708 0.993 P06708 →
Q1A7B2 0.993 Q1A7B2 →
P02586 0.992 P02586 →
P06706 0.992 P06706 →
Q1A7B1 0.992 Q1A7B1 →
Q09665 0.992 Q09665 →
O14008 0.992 O14008 →
D2DGW3 0.992 D2DGW3 →
P21797 0.991 P21797 →
Q3SB14 0.991 Q3SB14 →